KDM5B and neoplasm: Dysregulated histone demethylase activity, particularly of KDM5B, as well as diminished H4K20me3 levels have been observed in OS and are associated with increased tumor aggressiveness and resistance to chemotherapy, suggesting their involvement in tumor progression and drug resistance [30].